Search Within

Emily H Cheng

  1. "Body Imaging Service"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (1)
Groups
  1. Body Imaging Service (5)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (5)
  3. Department of Pathology and Laboratory Medicine (5)
  4. GSK Faculty (5)
  5. Human Oncology and Pathogenesis Program (5)
  6. Radiology, Department of (5)

More Groups

People
  1. Abraham Hakimi (4)
  2. Yingbei Chen (4)
  3. Can Pham (3)
  4. James Hsieh (3)
  5. Martin Voss (3)
  6. Omer Aras (3)

More People

Years
  1. 2019 (1)
  2. 2017 (2)
  3. 2014 (1)
  4. 2013 (1)
Publications
  1. Cancer Research (2)
  2. Cell Reports (1)
  3. Clinical Cancer Research (1)
  4. European Urology Focus (1)
Publishers
  1. American Association for Cancer Research (3)
  2. Cell Press (1)
  3. Elsevier B.V. (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hyperpolarized MRI visualizes Warburg effects and predicts treatment response to mTOR inhibitors in patient-derived ccRCC xenograft models
    Journal Article

    Dong, Y.; Eskandari, R.; Ray, C.; Granlund, K. L.; Dos Santos-Cunha, L.; Miloushev, V. Z.; Tee, S. S.; Jeong, S.; Aras, O.; Chen, Y. B.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Tumor xenografts of human clear cell renal cell carcinoma but not corresponding cell lines recapitulate clinical response to sunitinib: Feasibility of using biopsy samples
    Journal Article

    Dong, Y.; Manley, B. J.; Becerra, M. F.; Redzematovic, A.; Casuscelli, J.; Tennenbaum, D. M.; Reznik, E.; Han, S.; Benfante, N.; Chen, Y. B.; more...
    European Urology Focus (2017)

    Fulltext@MSK | Save
  • The SWI/SNF protein PBRM1 restrains VHL-loss-driven clear cell renal cell carcinoma
    Journal Article

    Nargund, A. M.; Pham, C. G.; Dong, Y.; Wang, P. I.; Osmangeyoglu, H. U.; Xie, Y.; Aras, O.; Han, S.; Oyama, T.; Takeda, S.; more...
    Cell Reports (2017)

    Fulltext@MSK | Save
  • Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
    Journal Article

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Pathway convergent evolution underscores treatment response to MTOR inhibitors in kidney cancers
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save